Total Payments
$140,613
2024 Payments
$300.88
Companies
23
Transactions
159
Medicare Patients
4,893
Medicare Billing
$626,500
Payment Breakdown by Category
Research$135,289 (96.2%)
Food & Beverage$3,183 (2.3%)
Travel$2,141 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $135,289 | 18 | 96.2% |
| Food and Beverage | $3,183 | 130 | 2.3% |
| Travel and Lodging | $2,141 | 11 | 1.5% |
Payments by Type
Research
$135,289
18 transactions
General
$5,324
141 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc. | $135,289 | 18 | $0 (2018) |
| AstraZeneca UK Limited | $2,164 | 14 | $0 (2017) |
| Shionogi Inc | $781.35 | 10 | $0 (2020) |
| GlaxoSmithKline, LLC. | $447.61 | 28 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $437.37 | 18 | $0 (2022) |
| PFIZER INC. | $230.28 | 12 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $170.09 | 9 | $0 (2024) |
| Genentech USA, Inc. | $135.99 | 1 | $0 (2018) |
| Blueprint Medicines Corporation | $134.93 | 5 | $0 (2024) |
| GENZYME CORPORATION | $133.15 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $300.88 | 14 | Blueprint Medicines Corporation ($89.32) |
| 2023 | $360.58 | 17 | GlaxoSmithKline, LLC. ($82.19) |
| 2022 | $262.24 | 13 | GlaxoSmithKline, LLC. ($50.61) |
| 2021 | $178.68 | 11 | GlaxoSmithKline, LLC. ($42.74) |
| 2020 | $1,043 | 24 | Shionogi Inc ($781.35) |
| 2019 | $284.21 | 17 | Mylan Specialty L.P. ($101.93) |
| 2018 | $62,036 | 33 | Glenmark Pharmaceuticals Inc. ($61,384) |
| 2017 | $76,148 | 30 | Glenmark Pharmaceuticals Inc. ($73,906) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Immunology | ||||||
| 11/11/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Immunology | ||||||
| 10/01/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $34.05 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/26/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Inflammation | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/07/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $28.33 | General |
| Category: Oncology / Rare Diseases | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: RESPIRATORY | ||||||
| 07/01/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 05/03/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: IMMUNOLOGY | ||||||
| 04/22/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $26.94 | General |
| Category: Oncology / Rare Diseases | ||||||
| 11/07/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 11/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: RESPIRATORY | ||||||
| 09/09/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: RESPIRATORY | ||||||
| 09/01/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/24/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $18.60 | General |
| 08/23/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 08/08/2023 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Immunology | ||||||
| 07/10/2023 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Oncology / Rare Diseases | ||||||
| 05/02/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 04/18/2023 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| GSP 301-303 | Glenmark Pharmaceuticals Inc. | $58,450 | 6 |
| GSP301-304 | Glenmark Pharmaceuticals Inc. | $15,456 | 5 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,285 | 15,096 | $544,941 | $181,130 |
| 2022 | 15 | 1,295 | 15,398 | $474,632 | $162,162 |
| 2021 | 13 | 1,192 | 14,957 | $442,194 | $153,343 |
| 2020 | 12 | 1,121 | 14,391 | $408,576 | $129,865 |
Total Patients
4,893
Total Services
59,842
Medicare Billing
$626,500
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 525 | $91,875 | $46,705 | 50.8% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2023 | 198 | 4,050 | $101,250 | $41,577 | 41.1% |
| 95117 | Professional service for multiple injections of allergen | Office | 2023 | 164 | 3,807 | $152,280 | $30,648 | 20.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 83 | 4,169 | $50,028 | $10,972 | 21.9% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 15 | 358 | $28,640 | $10,414 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 70 | 70 | $16,800 | $8,320 | 49.5% |
| 95115 | Professional service for single injection of allergen | Office | 2023 | 44 | 969 | $26,163 | $6,492 | 24.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 15 | 122 | $9,150 | $4,348 | 47.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 114 | $10,260 | $4,144 | 40.4% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 13 | 66 | $8,710 | $3,243 | 37.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 99 | 120 | $16,800 | $3,098 | 18.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 31 | $4,030 | $2,078 | 51.6% |
| 94016 | Test to measure expiratory airflow and volume initiated by patient and evaluated by provider | Office | 2023 | 85 | 97 | $7,275 | $1,551 | 21.3% |
| 95024 | Test for allergy using allergenic extract injected into skin | Office | 2023 | 36 | 255 | $3,825 | $1,544 | 40.4% |
| 95012 | Test to measure the level of nitric oxide gas | Office | 2023 | 98 | 116 | $4,640 | $1,462 | 31.5% |
| 95018 | Test for allergy using combination of methods with drug or biological | Office | 2023 | 11 | 91 | $4,095 | $1,385 | 33.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 33 | $3,300 | $1,232 | 37.3% |
| 95076 | Test for allergy using ingested items, initial 2 hours | Office | 2023 | 11 | 11 | $1,880 | $1,042 | 55.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 30 | 72 | $3,240 | $738.34 | 22.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 20 | 20 | $700.00 | $136.32 | 19.5% |
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 202 | 4,012 | $100,300 | $42,736 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 239 | 436 | $68,045 | $39,792 | 58.5% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 154 | 3,666 | $145,925 | $29,646 | 20.3% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 112 | 5,286 | $63,152 | $15,182 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 93 | 93 | $20,220 | $11,816 | 58.4% |
About Dr. Pramila Daftary, M.D
Dr. Pramila Daftary, M.D is a Specialist healthcare provider based in Waco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255399945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pramila Daftary, M.D has received a total of $140,613 in payments from pharmaceutical and medical device companies, with $300.88 received in 2024. These payments were reported across 159 transactions from 23 companies. The most common payment nature is "" ($135,289).
As a Medicare-enrolled provider, Daftary has provided services to 4,893 Medicare beneficiaries, totaling 59,842 services with total Medicare billing of $626,500. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Waco, TX
- Active Since 05/02/2006
- Last Updated 03/30/2017
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255399945
Products in Payments
- NUCALA (Biological) $262.86
- DUPIXENT (Biological) $257.08
- EUCRISA (Drug) $140.06
- Xolair (Biological) $135.99
- Yupelri (Drug) $123.22
- FASENRA (Drug) $115.91
- AYVAKIT (Drug) $110.49
- XOLAIR (Drug) $103.55
- TRELEGY ELLIPTA (Drug) $95.50
- CUVITRU (Biological) $89.84
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $76.07
- XOLAIR (Biological) $66.54
- SYMBICORT (Drug) $61.88
- TEZSPIRE (Biological) $55.96
- BREO (Drug) $48.69
- Haegarda (Biological) $45.23
- AREXVY (Drug) $40.56
- AUVI-Q (Drug) $33.96
- PANZYGA (Biological) $33.86
- Odactra (Drug) $33.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Waco
Dr. William Peper, M.d, M.D
Specialist — Payments: $38,981
Specialist $38,981
Dr. Johnny Howton, M.d, M.D
Specialist — Payments: $32,689
Specialist $32,689
Dr. Richard Helmer, Md, MD
Specialist — Payments: $19,311
Specialist $19,311
Joseph Browder, Md, MD
Specialist — Payments: $13,189
Specialist $13,189
Robert Wright, Md, MD
Specialist — Payments: $9,909
Specialist $9,909
Dr. Donald Young, M.d, M.D
Specialist — Payments: $7,387
Specialist $7,387